GLP-1 Receptor Agonists in Paediatric obesity: An Umbrella Review [abstract only]

M1: National evaluation insights to shape the future of England's CEW clinics for children and young people: findings from ENHANCE M2: How are we still getting it wrong?Addressing pitfalls in transdisciplinary obesity research across the life course M3: Beyond GLP-1 medications: why behavioural and psychological support still matters in weight management M4: Co-designing dietary guidance for obesity management medications: the evolving role of dietitians and pathway innovations across the devolved nations Oral sessions O1: Maternal obesity and reproductive health: advancing evidence from preconception to pregnancy O2: Exploring specialist weight management and wider stakeholders O3: Reframing and rethinking our approach to weight management: understanding the wider context and determinants O4: Exploring the lived experience of obesity and complications during weight management in children O5: Rethinking how we approach weight managementlocal authority practice, systems approaches and digital delivery O6: Exploring the lived experience of obesity and complications during weight management in adults O7: Understanding the efficacy of and heterogeneity in medication use for weight management Poster sessions P01-P80 ASO BEST PRACTICE AWARD A1 More than weight (2025) report-an independent research study exploring the human, social and economic costs of obesity in West Yorkshire and Humber and North Yorkshire ICB populations